CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
Lund, Sweden – April 8, 2019 - Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’s imILT® immuno-stimulating method for treating cancer tumours at the European Conference on Interventional Oncology (ECIO) in Amsterdam, the Netherlands this April 8-11, 2019. The white paper’s “Scientific Background” includes pre-clinical and clinical studies, treatment method developments, and data on safety and usability topics. The full “imILT